About Us
- News and Announcements
- Newsletter
- Our Team
- Publications
- Support Our Work
- Contact Us
Our Center News
__________________________________________________________________________________________________________
UCSD Center of Excellence is currently enrolling for the INVEST-HD Novartis Study!
We are thrilled to announce that we have begun enrolling participants for the INVEST-HD clinical trial from Novartis. INVEST-HD is a double-blind, placebo-controlled trial investigating the efficacy of Votoplam in slowing the progression of Huntington's disease. Votoplam is a once-daily oral medication that reduces Huntingtin protein levels. If you are interested in learning more about INVEST-HD and other upcoming clinical trials, please reach out to our site today!UCSD Named Center of Excellence
UC San Diego is one of 56 centers nationwide, and 11 partner sites, to receive the prestigious designation of Center of Excellence by the Huntington's Disease Society of America, which recognizes centers for their elite multidisciplinary approach to Huntington’s disease care and research. This is the 20th consecutive year that UCSD has earned the HDSA Center of Excellence designation.
The HDCRC is on Social Media!
UCSD Huntington's Disease Clinical Research Center is on Twitter! We are entering a new phase here at the HDCRC that will enable us to engage more with the HD Community! Be on the lookout for new social media updates. And don't forget to join our mailing list to receive updates directly to your inbox!